Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

United Therapeutics sell Bank of America Co.

Start price
€300.50
01.08.24 / 50%
Target price
€259.28
01.08.25
Performance (%)
-15.67%
End price
€253.40
02.08.25
Summary
This prediction ended on 02.08.25 with a price of €253.40. The price of United Therapeutics decreased from the start of the prediction. Compared to the start price this resulted in a performance of -15.67%. Bank_of_America_Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
United Therapeutics 1.594% 1.594% 20.395%
iShares Core DAX® 1.803% 0.496% 18.553%
iShares Nasdaq 100 0.429% -0.410% 8.908%
iShares Nikkei 225® 0.708% -3.799% 12.088%
iShares S&P 500 0.288% -0.218% 3.736%

Comments by Bank_of_America_Co_ for this prediction

In the thread United Therapeutics diskutieren
Prediction Sell
Perf. (%) -15.67%
Target price 259.280
Change
Ends at 01.08.25

United Therapeutics Co. (NASDAQ: UTHR) had its price target lowered by analysts at Bank of America Co. from $303.00 to $280.00. They now have an "underperform" rating on the stock.
Ratings data for UTHR provided by MarketBeat

In the thread Trading United Therapeutics
Prediction Sell
Perf. (%) -15.67%
Target price 259.280
Change
Ends at 01.08.25

Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten